SCI - Latest News
Service Corporation International (SCI), operates in Consumer Cyclical / Personal Products & Services, trades on NYSE.
Market capitalization stands near $10.40B. Trailing twelve-month P/E ratio is 16.76. Beta to the broader market is 0.81.
The article list below shows the most recent SCI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent SCI Headlines
SCI Stock Surges Nearly 113% in a Year: What's Behind the Rally?
zacks.com - Sep 30, 2026
SCIA is benefiting from stronger demand, new customers, higher volume and advanced-materials expansion, but concentration and supply-chain risks remai
Zacks Initiates Coverage of SCI With Neutral Recommendation
zacks.com - Sep 29, 2026
Discover why Zacks rates SCI as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore SCIA's additive manufacturing ex
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
businesswire.com - Sep 15, 2026
VIENNA, Va. --(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI invited to deliver keynote address on Multikine at 6th World Congress on Otology, Rhinology
Service Corporation International (NYSE:SCI) Shares Pass Below Fifty Day Moving Average – Here’s Why
defenseworld.net - Sep 4, 2026
Service Corporation International (NYSE: SCI - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Thursday. The
NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
thenewswire.com - Aug 31, 2026
Toronto, Ontario, August 31, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage pharmaceuti
How News Affects SCI Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track SCI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked SCI news questions
- What is the latest SCI news headline?
- The most recent SCI headline (Sep 30, 2026) is "SCI Stock Surges Nearly 113% in a Year: What's Behind the Rally?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the SCI news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What SCI news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual SCI options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.